Skip to content

Clinical trials

Phase 3 Purpura, Thrombocytopenic, Idiopathic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Purpura, Thrombocytopenic, Idiopathic Phase: Phase 3 Clear all

109 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20043
20056
20065
20074
20083
20092
20101
20114
20128
20132
20148
20154
20166
20174
20183
20195
20206
20217
20228
20233
20241
20259
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed65
Recruiting12
Unknown status12
Withdrawn7
Active, not recruiting5
Terminated5
Not yet recruiting3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shandong University15
Amgen10
argenx6
GlaxoSmithKline4
Novartis Pharmaceuticals4
Assistance Publique - Hôpitaux de Paris3
Jiangsu HengRui Medicine Co., Ltd.3
Ostfold Hospital Trust3
Rigel Pharmaceuticals3
Sobi, Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Purpura, Thrombocytopenic, Idiopathic109
Thrombocytopenia24
Purpura12
Purpura, Thrombocytopenic9
Hemorrhage8
Hematologic Diseases5
Autoimmune Diseases3
Blood Platelet Disorders3
Hemorrhagic Disorders3
Hemostatic Disorders3

Trials

Showing 26 to 50 of 109. Each trial links to its page on Pharma Observatory.

9 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.